1. Home
  2. RDCM vs TOI Comparison

RDCM vs TOI Comparison

Compare RDCM & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radcom Ltd.

RDCM

Radcom Ltd.

HOLD

Current Price

$14.44

Market Cap

270.2M

Sector

Technology

ML Signal

HOLD

Logo The Oncology Institute Inc.

TOI

The Oncology Institute Inc.

HOLD

Current Price

$4.10

Market Cap

304.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDCM
TOI
Founded
1985
2007
Country
Israel
United States
Employees
N/A
641
Industry
Computer peripheral equipment
Medical/Nursing Services
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.2M
304.4M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
RDCM
TOI
Price
$14.44
$4.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$18.00
$6.67
AVG Volume (30 Days)
242.5K
1.4M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.50
$30.15
Revenue Next Year
$9.74
$25.77
P/E Ratio
$16.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.41
$2.02
52 Week High
$16.74
$4.88

Technical Indicators

Market Signals
Indicator
RDCM
TOI
Relative Strength Index (RSI) 44.92 63.16
Support Level $12.93 $3.35
Resistance Level $14.44 $4.15
Average True Range (ATR) 0.63 0.25
MACD -0.25 -0.01
Stochastic Oscillator 12.10 70.31

Price Performance

Historical Comparison
RDCM
TOI

About RDCM Radcom Ltd.

Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.

Share on Social Networks: